MEET OUR EXPERTS
Leading an evolution in neurology diagnostics
Mayo Clinic neurologists will be available April 19–22 at booth 5018 from noon to 1PM. Stop by to meet the experts who designed and implemented this testing.
Clinically backed neurology and neurogenetics testing
Powered by expertise from our research labs, clinical labs, and clinical practice, Mayo Clinic Laboratories has developed panels customized to address specific autoimmune neurology and neurogenetic phenotypes. For patients with neurologic conditions, this testing can provide life-changing answers.
Connect with us at the American Academy of Neurology Annual Meeting to learn how our evaluations can inform your clinical practice. Drop by to talk to one of our experts about:
- Why our evaluations are at the leading edge of testing.
- Our collaborative approach to test development.
- The impact our testing has on patient care.
ExPERTs schedule
| Date & Time | Neuroimmunology | Behavioral Neurology | Muscle & Nerve |
|---|---|---|---|
| Sunday, April 19th from 12 - 1PM | Christopher Klein, M.D. & Eoin Flanagan, M.B., B.Ch. | Stuart McCarter, M.D. | Margherita Milone, M.D., Ph.D. |
| Monday, April 20th from 12 - 1PM | Divyanshu Dubey, M.B.B.S. & Anastasia Zekeridou, M.D., Ph.D. | Ronald Petersen, M.D., Ph.D. | Sarah Berini, M.D. |
| Tuesday, April 21st from 12 - 1PM | Sean Pittock, M.D. | Vijay Ramanan, M.D., Ph.D. & Jonathan Graff-Radford, M.D. | Visit with Mayo Clinic Laboratories’ representatives during this time. |
| Wednesday, April 22nd from 12 - 1PM | Coming soon | Coming soon | Coming soon |
Highlights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to explore recent examples of diagnostic innovations that are improving patient care. Dr. Pritt also welcomes Matthew Schultz, Ph.D., a clinical biochemical geneticist at Mayo Clinic, to discuss how a novel test is delivering answers for patients with a recently identified peripheral neuropathy.
This presentation offers a clear introduction to emerging blood based biomarkers for Alzheimer’s disease.
In this video, Dr. Vijay Ramanan shares perspectives on rational approaches to testing in the cognitive neurology, mild cognitive impairment, and dementia settings.
SAAmplify™-αSYN testing offers unprecedented accuracy in diagnosing Parkinson’s and Lewy body dementia.
After months of misdiagnoses, Tom Heisler found answers at Mayo Clinic, where advanced renal pathology revealed IgG4-related disease and led to his recovery.
Join us for a webinar exploring the revolutionary way SAAmplify™–αSYN testing, which is offered by Mayo Clinic Laboratories in collaboration with Amprion, is improving diagnostic accuracy for patients with neurodegenerative disorders.
Diagnostic advances allow earlier & more accurate detection of Alzheimer's using cerebrospinal fluid biomarkers.
After mysterious neurological symptoms began in 2010, Brad Karon, M.D., Ph.D., was diagnosed with paraneoplastic syndrome, a rare condition that led to groundbreaking research and test development at Mayo Clinic. Years later, pulmonary fibrosis and a double lung transplant would test him once again — and redefine his resilience.
For many, the path to a correct diagnosis can be long and filled with uncertainty. This story highlights the resilience and determination of one patient who navigated a complex medical journey to find answers and hope at Mayo Clinic. The patient asked to remain anonymous for personal privacy reasons.
In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by Russ Lebovitz, M.D., Ph.D., CEO and co-founder of Amprion. They discuss their strategic collaboration and the innovative SAAmplify™–αSYN (CSF) test.
By using a test that measures neurofilament light chain (Nfl) proteins in blood, clinicians can better diagnose devastating diseases like ALS and MS, help predict disease progression, and better assess efficacy of existing drugs and trial therapies.
Mayo Clinic Laboratories is thrilled to participate in the American Academy of Neurology (AAN) Annual Meeting, which will be held in San Diego on April 5–9, 2025. Our lab and clinical experts are leading an evolution in neurology diagnostics and are committed to staying at the forefront of discovery.